SIFT | AML patients | Healthy controls in the 1000 Genomes Project | |||||||
---|---|---|---|---|---|---|---|---|---|
Score | Impact | No. of variants | % | No. of variants | % | No. of variants | % | No. of variants | % |
0 | Damaging | 131 | 26.52 | 421 | 18.21 | 339 | 17.51 | 333 | 19.44 |
0.001-0.050 | Damaging | 73 | 14.78 | 375 | 16.22 | 290 | 14.99 | 260 | 15.18 |
0.051-0.100 | Potentially damaging | 25 | 5.06 | 173 | 7.48 | 146 | 7.55 | 129 | 7.53 |
0.101-0.200 | Borderline | 28 | 5.67 | 295 | 12.76 | 242 | 12.51 | 190 | 11.09 |
0.201-0.500 | Tolerant | 63 | 12.75 | 441 | 19.07 | 358 | 18.50 | 326 | 19.03 |
0.501-0.999 | Tolerant | 53 | 10.73 | 298 | 12.89 | 245 | 12.66 | 212 | 12.38 |
1.00 | Tolerant | 121 | 24.49 | 309 | 13.37 | 315 | 16.28 | 263 | 15.35 |
Total | Â | 494 | 100.00 | 2312 | 100.00 | 1935 | 100.00 | 1713 | 100.00 |